Systolic blood pressure increase in chronic heart failure associates with survival advantage
Patients with chronic HF with SBP increase ≥10 mmHg over the first year have a 39% reduction in the all-cause mortality risk irrespective of basal SBP, severity of ventricular dysfunction, and evidence-based drug use. Patients with SBP stability or decrease have a similarly poor prognosis.
Authors
- Alexandra Toste
- Helena Rocha (ORCID: https://orcid.org/0000-0002-4741-7343)
- Jorge Almeida
- Rui Ribeiro (ORCID: https://orcid.org/0000-0003-4150-2325)
- Helena Reis (ORCID: https://orcid.org/0000-0003-3376-5256)
- Carlos Grijó (ORCID: https://orcid.org/0000-0002-7530-8750)
- Carolina V. Guimaraes (ORCID: https://orcid.org/0000-0002-6491-9425)
- Catarina Pinto Reis (ORCID: https://orcid.org/0000-0002-1046-4031)
- Ana Neves (ORCID: https://orcid.org/0000-0003-4471-1050)
- Ana Catarina Fonseca (ORCID: https://orcid.org/0000-0001-6913-5526)
- Patrícia Lourenço (ORCID: https://orcid.org/0000-0003-1076-4031)
- Catarina Elias (ORCID: https://orcid.org/0000-0002-7210-6854)
- Adriana Rodolfo da Costa (ORCID: https://orcid.org/0000-0002-0263-3309)
- Rita Gouveia
Institutions
- Universidade do Porto (PT)
- Hospital de São João (PT)
Publication Details
- Journal
- Porto Biomedical Journal
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1097/j.pbj.0000000000000284
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00